NSC 127716

Known as: NSC-127716 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2006
012319862006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A phase I trial and pharmacokinetic study of 5-aza-2'-deoxycytidine (5-aza-dCyd) were conducted in 21 patients with advanced… (More)
  • table 1
  • figure 2
  • table 2
  • table 3
  • figure 3
Is this relevant?
Review
2003
Review
2003
  • Drugs in R&D
  • 2003
Decitabine [NSC 127716, DAC, dezocitidine, Aza dC, 2'-deoxy-5-azacytidine, Dacogen( trade mark )] is a deoxycytidine and… (More)
Is this relevant?
Review
2003
Review
2003
  • Drugs in R&D
  • 2003
Decitabine [NSC 127716, DAC, dezocitidine, Aza dC, 2'-deoxy-5-azacytidine] is a deoxycytidine and cytarabine derivative with… (More)
Is this relevant?
Review
2003
Review
2003
Normal cell development and function is dependent upon controlled gene expression. DNA methylation is an epigenetic modification… (More)
Is this relevant?
1987
1987
The Early Clinical Trials Cooperative Group of the EORTC conducted several phase II studies with a pyrimidine analogue of… (More)
Is this relevant?
1986
1986
A phase I trial and pharmacokinetic study of 5-aza-2'-deoxycytidine (5-aza-dCyd) were conducted in 21 patients with advanced… (More)
  • table 1
  • figure 2
  • table 2
  • table 3
  • figure 3
Is this relevant?